Cardinal Health, Inc. – Consensus Indicates Potential -1.5% Downside

DirectorsTalk Interviews

Cardinal Health, Inc. with ticker code (CAH) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 80 and 56 and has a mean target at 69.54. With the stocks previous close at 70.63 this would indicate that there is a downside of -1.5%. The day 50 moving average is 62.01 while the 200 day moving average is 56.08. The market cap for the company is $19,046m. Visit the company website at: https://www.cardinalhealth.com

The potential market cap would be $18,752m based on the market concensus.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Share on:

Latest Company News

Helium demand accelerates as industries race to secure limited supply

Helium is no longer a niche gas, with global demand rising sharply across tech and industry as supply becomes a strategic priority.

Volta Finance shifts investment mandate to BNP Paribas

Volta Finance moves to BNP Paribas Asset Management Europe with no change to strategy, team or fees, reinforcing long-term investor continuity.

Touchstone returns to overlooked Trinidad acreage with promising new gas play

Touchstone hits thick gas zones in Trinidad’s Central block, confirming a new drilling target after nearly two decades of inactivity.

KEFI sets Tulu Kapi on a new development path

KEFI Gold and Copper secures US$340m in project funding plus US$30m in streaming finance to advance its flagship Tulu Kapi mine towards full production by 2027.

Drill results point to larger gold system at Ora Banda’s Sand King

Ora Banda’s latest drilling at Sand King points to a much larger gold system, with strong grades extending beyond current mine plans.

Tekmar lands long-term cable deal in UK offshore wind

Tekmar has secured a £7m contract to supply cable protection systems for a UK offshore wind project, with delivery expected from 2027.

    Search

    Search